凝血因子Ⅸ(F9)活性蛋白
Active Coagulation Factor IX (F9)
HEMB; FIX; GLA Domain; PTC; Anti Hemophilic Factor B; Christmas Factor; Plasma Thromboplastic Component; Christmas Disease; Hemophilia B
- 編號APA840Rb03
- 物種Oryctolagus cuniculus (Rabbit,兔) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點5.4
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1651 ¥ 4128 ¥ 8256 ¥ 24768 ¥ 61920
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Coagulation Factor IX, also known as Christmas Factor, is a secreted by the liver and plays a key role in the activation of the intrinsic clotting cascade. Factor IX consists of a Gla domain, two tandem EGF-like domains, an activation peptide, and an S1 serine protease domain. Mature human Factor IX shares approximately 81% amino acid sequence identity with mouse and rat Factor IX. Alternative splicing generates an additional isoform that lacks the first EGF-like domain. The activity of recombinant rabbit Coagulation Factor IX is measured by its ability to cleave a fluorogenic peptide substrate Mca-RPKPVE-Nval-WRK(Dnp)-NH2 in the assay buffer 100 mM Tris, 150 mM NaCl, 10 mM CaCl2, 0.05% (w/v) Brij-35, pH 8.0. The Coagulation Factor IX is diluted to 100 ug/ml in assay buffer, then activated with a final concentration of 10 ug/ml Thermolysin at 37 ℃ for 90min. Adding a final concentration of 10 mM 1,10 Phenanthroline to stop the activation. The activated Coagulation Factor IX is diluted to 6 ug/mL in assay buffer. Loading into a black well plate 50 μL of 6 ug/mL Coagulation Factor IX and start the reaction by adding 50 μL of 20 uM substrate, with a substrate blank containing 50 μL assay buffer, 50 μL substrate, and no Coagulation Factor IX. Then read at 320/405 nm in kinetic mode for 5 minutes. The specific activity of recombinant rabbit Coagulation Factor IX is > 20 pmol/min/μg.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Oryctolagus cuniculus (Rabbit,兔) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA840Rb03 | 凝血因子Ⅸ(F9)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA840Rb02 | 凝血因子Ⅸ(F9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA840Rb03 | 凝血因子Ⅸ(F9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA840Rb01 | 凝血因子Ⅸ(F9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA840Rb51 | 凝血因子Ⅸ(F9)多克隆抗體 | WB; IHC; ICC; IP. |
LAA840Rb71 | 凝血因子Ⅸ(F9)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA840Rb21 | 凝血因子Ⅸ(F9)單克隆抗體 | WB |
MAA840Rb22 | 凝血因子Ⅸ(F9)單克隆抗體 | WB; IHC; ICC; IP. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Cardiovascular?Research | Loss of accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity [Pubmed:29444200] |